[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR920002795A - 항생제 발히마이신, 이의 제조방법 및 약제로서 이의 용도 - Google Patents

항생제 발히마이신, 이의 제조방법 및 약제로서 이의 용도 Download PDF

Info

Publication number
KR920002795A
KR920002795A KR1019910012751A KR910012751A KR920002795A KR 920002795 A KR920002795 A KR 920002795A KR 1019910012751 A KR1019910012751 A KR 1019910012751A KR 910012751 A KR910012751 A KR 910012751A KR 920002795 A KR920002795 A KR 920002795A
Authority
KR
South Korea
Prior art keywords
compound
medicament
carried out
dam
culturing
Prior art date
Application number
KR1019910012751A
Other languages
English (en)
Other versions
KR100221687B1 (ko
Inventor
루드라 나드카르니 수레쉬
차테르지 수가타
비탈브하이 파텔 마헤쉬
라자고팔란 데시칸 칼리아나푸람
코테스와라 사트야 비자야쿠마 에라
나레쉬 강굴리 비말
블룸바흐 위르겐
훼흘하버 한스-볼프람
코글러 헤르베르트
Original Assignee
이센브룩, 라피체
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이센브룩, 라피체, 훽스트 아크티엔게젤샤프트 filed Critical 이센브룩, 라피체
Publication of KR920002795A publication Critical patent/KR920002795A/ko
Application granted granted Critical
Publication of KR100221687B1 publication Critical patent/KR100221687B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/04—Actinomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음

Description

항생제 발히마이신, 이의 제조방법 및 약제로서 이의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 HPLC에서 발히마이신의 보유시간(retention time)을 나타낸다.
제2도는 H NMR(400MHz D2O, 300K)을 나타낸다.

Claims (12)

  1. 분자식 C66H73Cl2N9O24의 화합물인 발히마이신 및 약제학적으로 허용가능한 이의 염.
  2. 악티모마이세트 종 Y-86.21022(DAM 5809) 생산 미생물을 배양하고 이어서 배양 브로쓰로부터 분리 및 정제하여 수득할 수 있는 분자식 C66H73Cl2N9O24의 화합물인 발히마이신 및 약제학적으로 허용가능한 이의 염.
  3. 악티노마이세트 종 Y-86.21022(DAM 5809), 이의 돌연변이체 및/또는 변종을 탄소 및 질소원, 무기 영양염및 미량 원소를 함유하는 영양 배지 중에서 호기 조건하에 배양하고 통상적인 방법으로 화합물을 분리 및 정제함을 특징으로 하여, 제1항 또는 제2항에 청구된 발히마이신을 제조하는 방법.
  4. 제3항에 있어서, 배양을 약 28 내지 32℃의 온도 및 약 6 내지 8의 pH에서 수행하는 방법.
  5. 제3항 또는 제4항에서, 배양을 29℃(±1℃) 및 pH 약 7.0에서 수행하는 방법.
  6. 제3항 내지 제5항 중 어느 한 항에 있어서, 발효를 68 내지 72시간 동안 수행하는 방법.
  7. 제3항 내지 제6항중 어느 한 항에 있어서, 발효를 함침 발효로서 수행하는 방법.
  8. 제1항의 화합물 및, 필요한 경우, 추가로 약제 제조시에 통상적인 보조제 및/또는 부형제를 함유하는 약제.
  9. 항생 작용을 갖는 약제의 제조를 위한 제1항의 화합물의 용도.
  10. 항생제 생합성의 조절을 위한 생화학적 조절제로서의 제1항의 화합물의 용도.
  11. 악티노마이세트 종 Y-86.21022(DAM 5809).
  12. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910012751A 1990-07-27 1991-07-25 항생제 발히마이신, 이의 제조방법 및 이를 포함하는 약제 KR100221687B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP90119883.8 1990-07-27
EP90114471 1990-07-27
EP90114471.7 1990-07-27
EP90119883 1990-10-17

Publications (2)

Publication Number Publication Date
KR920002795A true KR920002795A (ko) 1992-02-28
KR100221687B1 KR100221687B1 (ko) 1999-10-01

Family

ID=26125378

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910012751A KR100221687B1 (ko) 1990-07-27 1991-07-25 항생제 발히마이신, 이의 제조방법 및 이를 포함하는 약제

Country Status (23)

Country Link
EP (1) EP0468504B1 (ko)
JP (1) JP3119680B2 (ko)
KR (1) KR100221687B1 (ko)
AT (1) ATE159261T1 (ko)
AU (1) AU648570B2 (ko)
CA (1) CA2047997C (ko)
CY (1) CY2114B1 (ko)
CZ (1) CZ282296B6 (ko)
DE (1) DE69127935T2 (ko)
DK (1) DK0468504T3 (ko)
ES (1) ES2108022T3 (ko)
FI (1) FI101402B1 (ko)
GR (1) GR3025433T3 (ko)
HR (1) HRP940710B1 (ko)
HU (1) HU215146B (ko)
IE (1) IE912643A1 (ko)
IL (1) IL98958A0 (ko)
IN (1) IN171883B (ko)
NO (1) NO305132B1 (ko)
NZ (1) NZ239130A (ko)
PT (1) PT98444B (ko)
RU (1) RU2043418C1 (ko)
YU (1) YU48601B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721208A (en) * 1991-06-29 1998-02-24 Hoechst Aktiengesellschaft Glycopeptides a process for their preparation and their use
TW213468B (ko) * 1991-06-29 1993-09-21 Hoechst Ag
DE19523394A1 (de) * 1995-06-28 1997-01-09 Hoechst Ag Verwendung von Balhimycin zur Leistungssteigerung bei Tieren sowie leistungssteigernde Mittel
CA2360865A1 (en) 1999-02-03 2000-08-10 Biogal Gyogyszergyar Rt. Process for the preparation of pseudomonic acid a antibiotic by microbiological method
DE19926770A1 (de) 1999-06-11 2000-12-14 Basf Ag Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067099A (en) * 1955-09-16 1962-12-04 Lilly Co Eli Vancomycin and method for its preparation

Also Published As

Publication number Publication date
CZ282296B6 (cs) 1997-06-11
DE69127935D1 (de) 1997-11-20
PT98444A (pt) 1992-05-29
JPH04261200A (ja) 1992-09-17
DE69127935T2 (de) 1998-03-19
GR3025433T3 (en) 1998-02-27
YU48601B (sh) 1998-12-23
HRP940710B1 (en) 2001-02-28
HU215146B (hu) 2000-03-28
FI913569A (fi) 1992-01-28
CY2114B1 (en) 2002-04-26
DK0468504T3 (da) 1998-06-02
AU8145391A (en) 1992-01-30
HUT61606A (en) 1993-01-28
NO305132B1 (no) 1999-04-06
CA2047997C (en) 2002-04-30
NO912931L (no) 1992-01-28
FI913569A0 (fi) 1991-07-25
HU912516D0 (en) 1992-01-28
PT98444B (pt) 1999-01-29
JP3119680B2 (ja) 2000-12-25
NO912931D0 (no) 1991-07-26
KR100221687B1 (ko) 1999-10-01
FI101402B (fi) 1998-06-15
ES2108022T3 (es) 1997-12-16
AU648570B2 (en) 1994-04-28
CA2047997A1 (en) 1992-01-28
YU128491A (sh) 1994-12-28
EP0468504B1 (en) 1997-10-15
IE912643A1 (en) 1992-01-29
FI101402B1 (fi) 1998-06-15
IL98958A0 (en) 1992-07-15
HRP940710A2 (en) 1997-06-30
RU2043418C1 (ru) 1995-09-10
NZ239130A (en) 1993-09-27
ATE159261T1 (de) 1997-11-15
CS233491A3 (en) 1992-03-18
EP0468504A1 (en) 1992-01-29
IN171883B (ko) 1993-01-30

Similar Documents

Publication Publication Date Title
DK161091C (da) Svovlholdige antibiotiske forbindelser med antitumorvirkning, betegnet cl-1577a og cl-1577b, fremgangsmaade til fremstilling deraf, samt farmaceutiske praeparater indeholdende forbindelserne
KR960700346A (ko) 면역억제제의 제조방법 및 이에 사용되는 신규 미생물(a process for producing immunosuppressives and a novel microbial species to be employed therein)
KR890002214A (ko) 데만노실 테이코플라닌 유도체
KR900003206A (ko) 항생물질 머사시딘, 이의 제조방법 및 약제로서의 이의 용도
KR920002795A (ko) 항생제 발히마이신, 이의 제조방법 및 약제로서 이의 용도
KR870004144A (ko) 항종양 항생제(ll-e33288 복합체)의 제법
KR890005139A (ko) 테이코플라닌 유사 유도체
US4487761A (en) Dopamine β-hydroxylase inhibitors
KR840004442A (ko) 란카시딘의 개량 제조방법
ES395935A1 (es) Un procedimiento para la produccion del antibiotico de ws- 4.545.
ES2056967T3 (es) Ws-9326a, ws-9326b y sus derivados.
EP0139457A3 (en) An antibiotic compound and its production
ES2080068T3 (es) Derivados de 2-piranona y su procedimiento de preparacion.
KR910014509A (ko) 항생성 알리사마이신, 이의 제조방법 및 용도
BG40969A3 (en) Method for preparing antibiotic sisomycine
KR910002457A (ko) 항 비루스 항생제 bu-3889v
BG44030A3 (en) Method for preparing of antibiotic a80190
KR850006451A (ko) 항생제 LL-D42067α 및 LL-D42067β의 제조방법
JPS55118396A (en) Preparation of mitomycin derivative
ES409978A1 (es) Metodo para la produccion de antibioticos no nitrogenados acidos.
JP3530563B2 (ja) Ｋｏ−８１１９物質及びその製造法
KR860002574A (ko) 항생물질 at 2433 복합체의 제조방법
EP0136923A3 (en) 2-amino-1,9-dihydro-6h-purin-6-one-7-oxide, the pharmaceutically acceptable salts and a process for the production thereof
KR840007604A (ko) 19-에피-디아네마이신의 제조방법
GB1388198A (en) Antibiotic fr-1923 and a process for the preparation thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020510

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee